Multitask learning improves prediction of cancer drug sensitivity
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Precision oncology seeks to predict the best therapeutic option for individual patients based on the molecular characteristics of their tumors. To assess the preclinical feasibility of drug sensitivity prediction, several studies have measured drug responses for cytotoxic and targeted therapies across large collections of genomically and transcriptomically characterized cancer cell lines and trained predictive models using standard methods like elastic net regression. Here we use existing drug response data sets to demonstrate that multitask learning across drugs strongly improves the accuracy and interpretability of drug prediction models. Our method uses trace norm regularization with a highly efficient ADMM (alternating direction method of multipliers) optimization algorithm that readily scales to large data sets. We anticipate that our approach will enhance efforts to exploit growing drug response compendia in order to advance personalized therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyd, S., Parikh, N., Chu, E., Peleato, B., & Eckstein, J. (2011) · Foundations and Trends® in Machine Learning · doi:10.1561/2200000016 · Cited by 17,075
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · cited 4×
“…the drug’s mechanism of action; for example, the elastic net prediction model for the MEK inhibitor PD-0325901 presented by Barretina et al. contained activating mutations in BRAF and NRAS as predictive features and achieved good prediction performance in cross-validation on cell lines 9 .”
InfluentialCaruana, R. (1997) · Machine Learning · doi:10.1023/a:1007379606734 · Cited by 6,636
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · cited 3×
“Many of these studies evaluated whether standard machine learning methods, trained on pharmacological data sets, can predict drug response from the genomic and transcriptomic features of cancer cells 9,11,13,16–19 .”
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · cited 1×
“…therapeutics, providing resources like the NCI-60 drug sensitivity database 8 , the Cancer Cell Line Encyclopedia (CCLE) 9 , the Cancer Target Discovery and Development small molecule screening data set (CTD2) 10 , and the Genomics of Drug Sensitivity in Cancer (GDSC) 11,12 , among others 13–15 .”
Inconsistency in large pharmacogenomic studies
Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C., Beck, A. H., Aerts, H. J. W. L., & Quackenbush, J. (2013) · Nature · doi:10.1038/nature12831 · Cited by 499 · cited 2×
“Barriers to improved prediction performance include the limited number of cell line training examples, poorly quantified drug responses 20 (i.e. label noise), and the large number of often noisy features ( > 50,000 in many experiments), all of which require careful machine learning practices to…”
Kang, Y., Greaves, B., & Perry, R. R. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00343-7 · Cited by 12
Cited by
MOLI: multi-omics late integration with deep neural networks for drug response prediction
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz318 · Cited by 421
Lenselink, E. B., ten Dijke, N., Bongers, B., Papadatos, G., van Vlijmen, H. W. T., Kowalczyk, W., IJzerman, A. P., & van Westen, G. J. P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0232-0 · Cited by 334
“Nevertheless, multi-task learning has been shown to outperform other methods in bioactivity modeling and the reader is referred to Yuan et al. [17] for a more in depth analysis.”
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
Lee, S.-I., Celik, S., Logsdon, B. A., Lundberg, S. M., Martins, T. J., Oehler, V. G., Estey, E. H., Miller, C. P., Chien, S., Dai, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02465-5 · Cited by 327
A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action
Yang, J. H., Wright, S. N., Hamblin, M., McCloskey, D., Alcantar, M. A., Schrübbers, L., Lopatkin, A. J., Satish, S., Nili, A., Palsson, B. O., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.016 · Cited by 321
The transformational role of GPU computing and deep learning in drug discovery
Pandey, M., Fernandez, M., Gentile, F., Isayev, O., Tropsha, A., Stern, A. C., & Cherkasov, A. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00463-x · Cited by 255
“…and their adverse effects 42 , the prediction of small molecule–protein binding 43 , the determination of chemotherapeutic responses of carcinogenic cells 44 , the quantitative estimation of drug sensitivity 45 and quantitative structure–activity relationship (QSAR) modelling 46 , among others.”
Background
Metadata
- Authors
- Yuan, H., Paskov, I., Paskov, H., González, A. J., & Leslie, C. S.
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31619-31619
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2513486311
- Cited by
- 105
- References
- 8
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multitask learning improves prediction of cancer drug sensitivity. https://app.cochat.ai/papers/10.1038/srep31619
- The paper
- Yuan, H., Paskov, I., Paskov, H., González, A. J., & Leslie, C. S. (2016). Multitask learning improves prediction of cancer drug sensitivity. Scientific Reports. https://doi.org/10.1038/srep31619
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.